A 10 year service evaluation of the survival of 439 patients with early oestrogen receptor positive breast cancer who underwent initial OncotypeDX ® testing to guide adjuvant chemotherapy decisions

A 10 year service evaluation of the survival of 439 patients with early oestrogen receptor positive breast cancer who underwent initial OncotypeDX ® testing to guide adjuvant chemotherapy decisions

Objective: To explore the long-term outcome of patients who underwent Oncotype DX® testing. The relationship between the RS, adjuvant treatments received, and clinical outcomes across the entire range of RS results are reported. Methods: 10-year Kaplan–Meier estimates for distant recurrence/BC-speci...

Full description

Bibliographic Details
Main Authors: Asma Munir, Simon Holt, Anita Marie Huws, Sohail Khan, Dr Mark Davies, Saira Khawaja, Yousef Sharaiha
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Breast cancer
Oncotype DX
Oestrogen receptor
Ki67
HER2
Chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222001629

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222001629

Similar Items